Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bearish
United States Health Care
Biopharma Week in Review : Pharma Tariffs Overhang; Worrying Vaccine Comments from RFK Jr.
Thematic (Sector/Industry)
232 Views
15 Apr 2025 19:47
Issuer-paid
The 90-day pause in reciprocal tariffs was a short-lived reprieve for biopharma, as Trump later clarified pharma tariffs were not part of the pa
What is covered in the Full Insight:
Biopharma Market Performance
Impact of Pharma Tariffs
RFK Jr.'s Vaccine Comments
Company News and Stock Performance
Regulatory and Market Outlook
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 7-minute read)
Related Insights
More »
Trump Team's Weird Tariff Math - Not Meant to Be Negotiated
Global Markets Plummet as Recession Fears, Weak Jobs Report, and Israel-Iran Conflicts Escalate
This Bull Run Is Nowhere Near Finished
2023 Shareholder Letter
SPY: Moderate Gains In Store?
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Philippines
Event-Driven
Sell / Short Ideas
India
Asia Event-Driven
South Korea
Credit
United States
Trending Insights
More »
Gold Miners ETF (GDX US): Big Outperformance Driven by Benchmark Change; Valuation Gap Opens Up
Quiddity Leaderboard STAR 50/100 Sep25: Final Expectations; New Pair Trades
China A50 ETFs Rebalance Preview: Three Changes in September
Sun Corp (6736) - CLBT Has Round-Tripped, But Now Better ParentCo and a Buyback so Set-Up Is Better
Kangji Medical (9997 HK): TPG/QIA/Founder's Offer Is No Knockout
Top Unpaywalled Insights
More »
Tradesmen's Collective: Fixing the Trades with Tech, Transparency & Boots-on-the-Ground
VEON 2Q25: Solid Digital Non-Telco Products Uplift, Kyivstar Listing in Focus
[IO Technicals 2025/32] Bullish Momentum Builds
Grab Holdings (GRAB US) - Harvesting Sequentially
Micro-Mechanics (Holdings) Limited - Next Generation Supplier of the Semicon Industry
Discussions
(Paid Plans Only)
Insight Stream
Biopharma Week in Review : Pharma Tariffs Overhang; Worrying Vaccine Comments from RFK Jr.
15 Apr 2025
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x